Cite
HARVARD Citation
Zhang, P. et al. (2016). Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients. Journal of hematology & oncology. 9 (1), pp. 1-9. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhang, P. et al. (2016). Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients. Journal of hematology & oncology. 9 (1), pp. 1-9. [Online].